MP
Mike Polark Wolfe Research Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
BBNX
1
Beta Bionics, Inc. Common Stock
BBNX
$874M
| $20.10 | $20 |
1%
downside
| Outperform | 3 months ago |
|
2
LivaNova
LIVN
$3.18B
| $58.15 | $60 |
3%
upside
| Outperform | 3 months ago |
|
3
Insulet
PODD
$24.4B
| $346.47 | $350 |
1%
upside
| Outperform | 3 months ago |
|
4
Inspire Medical Systems
INSP
$2.55B
| $86.32 | $236 |
173%
upside
| Outperform | 4 months ago |
|
5
iRhythm Technologies
IRTC
$5.85B
| $182.17 | $150 |
18%
downside
| Outperform | 4 months ago |
|
|
KMTS
6
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$848M
| $16.51 | $29 |
76%
upside
| Outperform | 5 months ago |
|
7
Edwards Lifesciences
EW
$47.5B
| $80.96 | $60 |
26%
downside
| Underperform | 7 months ago |
|
8
ResMed
RMD
$40.1B
| $273.81 | $180 |
34%
downside
| Underperform | 11 months ago |
|
9
Stryker
SYK
$151B
| $394.34 | $405 |
3%
upside
| Outperform | 1 year ago |
|
|
10
LivaNova
LIVN
$3.18B
| $58.15 | $55 |
5%
downside
| Neutral | 1 year ago |
|
11
Intuitive Surgical
ISRG
$163B
| $454.52 | $503 |
11%
upside
| Outperform | 1 year ago |
|
|
12
iRhythm Technologies
IRTC
$5.85B
| $182.17 | $115 |
37%
downside
| Outperform | 1 year ago |
|
13
DexCom
DXCM
$31.7B
| $80.76 | $121 |
50%
upside
| Outperform | 2 years ago |
|
14
Sotera Health
SHC
$4.4B
| $15.50 | $25 |
61%
upside
| Outperform | 2 years ago |
|
15
Masimo
MASI
$7.77B
| $143.01 | $165 |
15%
upside
| Outperform | 3 years ago |
|
16
Neuropace
NPCE
$318M
| $9.61 | $13 |
35%
upside
| Outperform | 3 years ago |
|
|
17
Intuitive Surgical
ISRG
$163B
| $454.52 | $315 |
31%
downside
| Peer Perform | 3 years ago |
|
|
18
Inspire Medical Systems
INSP
$2.55B
| $86.32 | $270 |
213%
upside
| Peer Perform | 3 years ago |
|
|
19
ResMed
RMD
$40.1B
| $273.81 | $300 |
10%
upside
| Outperform | 3 years ago |
|
|
20
Neuropace
NPCE
$318M
| $9.61 | $26 |
171%
upside
| Outperform | 4 years ago |
|
21
Steris
STE
$24B
| $243.39 | $250 |
3%
upside
| Outperform | 4 years ago |
|
|
22
Sotera Health
SHC
$4.4B
| $15.50 | $31 |
100%
upside
| Outperform | 4 years ago |
|
|
23
Masimo
MASI
$7.77B
| $143.01 | $260 |
82%
upside
| Outperform | 5 years ago |
|